Table 2.
Studies | A clearly stated aim | Inclusion of consecutive patients | Prospective data collection | Endpoints appropriate to the aim of the study | Unbiased assessment of the study endpoint | A follow‐up period appropriate to the aims of study | Less than 5% loss to follow‐up | Prospective calculation of the sample size | An adequate control group | Contemporary groups | Baseline equivalence of groups | Adequate statistical analyses | Total score |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Broome 2014 | 2 | 2 | 2 | 2 | 0 | 2 | 2 | 0 | 2 | 0 | 1 | 1 | 16 |
Cien 2015 | 2 | 2 | 2 | 2 | 0 | 2 | 2 | 2 | 2 | 0 | 2 | 2 | 20 |
Emerson JR 2016 | 2 | 2 | 2 | 2 | 0 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 21 |
Horn 2015 | 2 | 2 | 2 | 2 | 0 | 2 | 0 | 0 | 2 | 0 | 2 | 2 | 16 |
Kirkness 2016 | 2 | 2 | 2 | 2 | 0 | 2 | 2 | 2 | 2 | 0 | 2 | 2 | 20 |
Sporer 2016 | 2 | 2 | 2 | 2 | 0 | 2 | 2 | 0 | 2 | 0 | 2 | 2 | 18 |
Torres 2017 | 2 | 2 | 2 | 2 | 0 | 2 | 2 | 0 | 2 | 0 | 2 | 2 | 18 |
Yu 2016 | 2 | 2 | 2 | 2 | 0 | 2 | 2 | 0 | 2 | 1 | 2 | 2 | 19 |